ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced that it will be exhibiting at…Read More
Femasys Inc to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medicine
